Becton Dickinson Long Term Debt 2010-2024 | BDX
Becton Dickinson long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- Becton Dickinson long term debt for the quarter ending June 30, 2024 was $18.131B, a 21.47% increase year-over-year.
- Becton Dickinson long term debt for 2023 was $14.738B, a 6.14% increase from 2022.
- Becton Dickinson long term debt for 2022 was $13.886B, a 18.84% decline from 2021.
- Becton Dickinson long term debt for 2021 was $17.11B, a 0.66% decline from 2020.
Becton Dickinson Annual Long Term Debt (Millions of US $) |
2023 |
$14,738 |
2022 |
$13,886 |
2021 |
$17,110 |
2020 |
$17,224 |
2019 |
$18,081 |
2018 |
$18,894 |
2017 |
$18,667 |
2016 |
$10,550 |
2015 |
$11,370 |
2014 |
$3,768 |
2013 |
$3,763 |
2012 |
$3,761 |
2011 |
$2,485 |
2010 |
$1,495 |
2009 |
$1,488 |
Becton Dickinson Quarterly Long Term Debt (Millions of US $) |
2024-06-30 |
$18,131 |
2024-03-31 |
$15,995 |
2023-12-31 |
$14,094 |
2023-09-30 |
$14,738 |
2023-06-30 |
$14,926 |
2023-03-31 |
$16,010 |
2022-12-31 |
$14,268 |
2022-09-30 |
$13,886 |
2022-06-30 |
$14,683 |
2022-03-31 |
$17,584 |
2021-12-31 |
$16,360 |
2021-09-30 |
$17,110 |
2021-06-30 |
$15,700 |
2021-03-31 |
$17,718 |
2020-12-31 |
$16,082 |
2020-09-30 |
$17,224 |
2020-06-30 |
$17,090 |
2020-03-31 |
$16,809 |
2019-12-31 |
$16,949 |
2019-09-30 |
$18,081 |
2019-06-30 |
$18,016 |
2019-03-31 |
$17,556 |
2018-12-31 |
$17,817 |
2018-09-30 |
$18,894 |
2018-06-30 |
$20,350 |
2018-03-31 |
$22,589 |
2017-12-31 |
$22,095 |
2017-09-30 |
$18,667 |
2017-06-30 |
$18,563 |
2017-03-31 |
$9,082 |
2016-12-31 |
$9,043 |
2016-09-30 |
$10,550 |
2016-06-30 |
$10,561 |
2016-03-31 |
$10,864 |
2015-12-31 |
$10,858 |
2015-09-30 |
$11,370 |
2015-06-30 |
$11,367 |
2015-03-31 |
$12,128 |
2014-12-31 |
$9,940 |
2014-09-30 |
$3,768 |
2014-06-30 |
$3,768 |
2014-03-31 |
$3,764 |
2013-12-31 |
$3,764 |
2013-09-30 |
$3,763 |
2013-06-30 |
$3,763 |
2013-03-31 |
$3,762 |
2012-12-31 |
$3,762 |
2012-09-30 |
$3,761 |
2012-06-30 |
$3,761 |
2012-03-31 |
$3,964 |
2011-12-31 |
$3,972 |
2011-09-30 |
$2,485 |
2011-06-30 |
$2,485 |
2011-03-31 |
$2,484 |
2010-12-31 |
$2,485 |
2010-09-30 |
$1,495 |
2010-06-30 |
$1,493 |
2010-03-31 |
$1,490 |
2009-12-31 |
$1,488 |
2009-09-30 |
$1,488 |
2009-06-30 |
$1,484 |
2009-03-31 |
$748 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$69.388B |
$19.372B |
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|